Navigation Links
Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients
Date:5/31/2009

ORLANDO, Fla., May 31 /PRNewswire-FirstCall/ -- Eli Lilly and Company announced today that Phase III trial data showed the addition of Lilly's GEMZAR(R) (gemcitabine HCl for injection) to the current standard of care provided a statistically significant increase in progression-free survival at three years for women with locally advanced cervical cancer.

Cervical cancer is the world's second most commonly diagnosed women's cancer, and the second most common cause of cancer death in women.(1)

The current standard of care for women with locally advanced cervical cancer consists of the chemotherapy cisplatin and radiation (chemoradiation). This has been the recommended course of treatment since 1999.

Results from this global, multicenter, open-label, randomized Phase III trial were presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) during an ASCO-sponsored press conference on May 31 at 8:30 a.m. EDT, and as an oral presentation at the meeting at 10:30 a.m. EDT (ASCO Abstract #CRA5507).(2)

With 515 patients evaluated, the data showed a statistically significant (p=0.029) increase in progression-free survival at three years for patients treated with the gemcitabine chemoradiation combination versus those treated only with chemoradiation (74% vs. 65%, respectively). Patients on the gemcitabine arm experienced significantly more grade 3/4 toxicities. Additionally, two patients on the gemcitabine arm died due to causes possibly attributed to treatment-related toxicities. Most side effects were hematologic, including anemia (low red blood cell count), neutropenia (low white blood cell count) and thrombocytopenia (low blood platelet count).

"While there have been tremendous advances in cervical cancer prevention in the form of early screening and vaccination, oncologists have essentially been using the same treatment standard for the last
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., Nov. 6 Philips Respironics appla... and Prevention (CDC) to raise awareness about an ...ufficiency. The CDC,s release of the first-ever go...es in sleeplessness is a milestone in quantifying ...g-time educator, industry leader and sleep therapy...
(Date:11/6/2009)...E PARK, N.C., Nov. 6 Chimerix, Inc...ailable antiviral therapeutics to address life-thr...pment of the company,s lead antiviral compound, CM...he Global Health Security Initiative (GHSI). CMX0...oped for the treatment of smallpox, as well as oth...
(Date:11/6/2009)... Caraco Pharmaceutical La...etorolac tromethamine ophthalmic solution, 0.5% fo... Administration (FDA) for Sun Pharma,s Abbreviated...74; opthalmic solution on the first day following ...herapeutically equivalent to Acular® Ophthalm...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Blood Sugar Spikes Send Testosterone Levels Down 48816 1Blood Sugar Spikes Send Testosterone Levels Down 48816 2Lloydspharmacy Reveals Hayfever Misery to Hit One in Two People by 2060 48811 1Lloydspharmacy Reveals Hayfever Misery to Hit One in Two People by 2060 48811 2Lloydspharmacy Reveals Hayfever Misery to Hit One in Two People by 2060 48811 3Researchers describe implausible chemistry that produces herbicidal compound 8817 1Researchers describe implausible chemistry that produces herbicidal compound 8817 2
...,s Recombinant Protective Antigen Anthrax Vaccine ...gen,s Adjuvant, SCOTTSDALE, Ariz., Aug. 7 Immune... BioSciences Holdings, Inc.,(OTC Bulletin Board: I...Transfer Agreement (MTA) with VaxGen Inc. (Pink Sh...gen will receive the pharmaceutically active,ingre...
... for Antibiotics Eliminated in 87 Percent of Patie...s -, PRINCETON, N.J., Aug. 7 DEFLUX(R) (non-anim...r the treatment of,vesicoureteral reflux (VUR) in ...ry tract infections (UTIs) in children with VUR by...July issue of the Journal of,Laparoendoscopic & Ad...
Other Medicine Technology:ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 2ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 3ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 4DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux 2DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux 3DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux 4
(Date:11/8/2009)...wire-USNewswire/ -- Today, the House of Representa..., Smith, Ellsworth and Lipinski amendment to the "...). The amendment maintains the current policy of p...efits packages that include abortion. It clarifies...ility credits and those who do not, can with their...
(Date:11/8/2009)...wire-USNewswire/ -- Pharmaceutical Research and Ma...nt Ken Johnson released the following statement re...We are disappointed, but not surprised by today,s ...rking Americans as well as nearly half of the memb... against the bill. ,, "While well intentioned, ...
(Date:11/8/2009)...o Sides With Working Families vs. Insurance Compan...ewswire/ -- On the heels of an historic late night...balanced health care reform bill, the Pennsylvania....S. representatives voted on HR 3962, the Affordab...tion, which passed Saturday evening by a vote of 2...
(Date:11/7/2009)...ewswire-USNewswire/ -- Speaker Nancy Pelosi spoke... the Affordable Health Care for America Act. The ... Below are the Speaker,s remarks. ,, "Madam Sp...t for our nation and for American families. For n...cal philosophy -- as far back as Teddy Roosevelt -...
(Date:11/7/2009)...e/ -- Calling this a "defining moment" for the Ame... J. James Rohack, M.D., today addressed medical st...dical specialty societies at the opening of the AM...h system reform will top the agenda. ,, (Logo: ...LOGO ) ,, "Over the next 72 hours, this AMA H...
Breaking Medicine News(10 mins):Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2
..., Israel, May 13 Lumenis Inc., a global,developer...d radiofrequency,devices for surgical, aesthetic, ...aunch of a Holmium Laser Enucleation of the Prosta...e of,clinical evidence suggests that HoLEP provide...
... proceeds despite non-compliance with California E...(CEQA)., LOS ANGELES, May 12 Providence Holy Cro...e planned expansion of its,Holy Cross Medical Cent...y held today appears to be an attempt to create,"f...
..., May 12 /PRNewswire-FirstCall/ - Med-Emerg Intern...revenue from continuing operations,for the three m...red to,$4.8 million for the same period in 2007 (a...ved to $179K,from a loss of ($106K) in 2007. The i...
..., Calif., May 12 (Nasdaq: WHRT, TSX:,WHT) World H...") announced,that the Toronto Stock Exchange ("TSX...g the eligibility for continued listing on the TSX...and,operating results, more specifically whether t...
...NT, Calif., May 12 Keck Graduate Institute (KGI),...t ceremony will feature,the graduation of KGI,s fi..., and the unveiling of KGI,s first donated artwork...ice president for academic affairs, dean of facult...
...E, N.Y., May 12 Fairbank Farms, a national,ground...elected ground beef,products produced at its Ashvi..., Shaw,s, BJ,s, and Wilson Farms retail outlets an.../13/08, 05/15/08, or a,"Julian date 124" on the pa...
Other Medicine News:Health News:Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting 2Health News:Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting 3Health News:Providence Holy Cross Medical Center Ignores Community, Environmental Concerns With Planned Expansion of Mission Hills Facility 2Health News:Med-Emerg International Inc. reports improved income from continuing operations 2Health News:Med-Emerg International Inc. reports improved income from continuing operations 3Health News:WorldHeart Notified of TSX Delisting Review 2Health News:KGI 2008 Commencement Features First PhD Graduate, Biotech Painting 2Health News:Fairbank Farms Issues Voluntary Recall for Selected Ground Beef Products 2
Gellhorn Pessary
Ring Pessary
Pyramis
...female urinary stress incontinence (SUI) with a mi...ic (BioArcTM SP) or a transobturator (BioArcTM TO)...em combining synthetic and biologic materials. It ...BioArc utilizes a polypropylene mesh for fixation ...
Medicine Products: